News - Page 166 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial

Psyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical Trial

Post published:July 7, 2021
Post category:Press Release

Read more about the article MYND Life Sciences Provides Corporate Update

MYND Life Sciences Provides Corporate Update

Post published:July 7, 2021
Post category:Press Release

Read more about the article Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Clerkenwell Signs First Multi-million Pound Contract with International Psychedelic Bio-tech Company

Post published:July 7, 2021
Post category:Press Release

Read more about the article Delix Therapeutics Expands Executive Leadership Team

Delix Therapeutics Expands Executive Leadership Team

Post published:July 6, 2021
Post category:Press Release

Read more about the article Horizons ETFs Rebalances World’s First Psychedelics ETF

Horizons ETFs Rebalances World’s First Psychedelics ETF

Post published:July 6, 2021
Post category:Press Release

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology

Post published:July 6, 2021
Post category:Press Release

Read more about the article Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical Study

Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical Study

Post published:July 6, 2021
Post category:Press Release

Read more about the article Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence

Post published:July 6, 2021
Post category:Press Release

Read more about the article COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

Post published:July 5, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?

Psychedelic Bulletin: Harvard Law School Launches Psychedelics Project; California Decrim. Bill Clears Latest Hurdle; LSD for Food Allergies?

Post published:July 2, 2021
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.